| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8519324 | Contemporary Clinical Trials Communications | 2018 | 5 Pages |
Abstract
SKCCC has a diverse portfolio of trials available for NSCLC patients and should consider research strategies to re-examine eligibility criteria for future trials to ensure increased enrollment of current smokers and stage 1 or 2 patients. We could not confirm whether type of initial visit was related to eligibility.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Jeffrey J. Hardesty, Norma F. Kanarek,